The more recent cases of COVID-19 seem to be coming from homes and family contacts, rather than from strangers. And there, with the "opening up" of social mobility, is an increasing interest in the spread and dispersion of airborne COVID-19 particles. There are lessons to be learned from atmospheric science, especially when it pertains to the dispersion of small particles.
COVID-19
Should Facebook be in the business of "debunking" news and scientific data when events are rapidly changing? What's true today may be declared false tomorrow, only to be declared true again a week later. Furthermore, does Facebook have the expertise to do so?
Are bald men more likely to get severe COVID-19? There are more than 30,000 news stories about this, almost all of which without question, accept the findings of a flawed epidemiological study from Spain. Is this a valid conclusion? Let's ask a biostatistician.
As an anti-coronavirus therapy, Remdesivir has been rather disappointing. That's primarily because the drug is given intravenously to those who are already very ill with COVID-19. But what would happen if the drug could be delivered directly to the lungs, to prevent severe disease? Gilead is giving it a shot. Here are some of the pros and cons of that approach.
Now that the paper published in The Lancet, on the use of hydroxychloroquine for COVID-19, has been retracted, we need to look at how eminence continues to trump evidence. When we talk about humans and their behavior, everything is political.
We tend to overlook how natural disasters like the coronavirus pandemic shape human behavior. Maybe that should change.
We're social animals, and we want to socialize. We're also lazy, and we want to do whatever is easiest or most convenient. Those two facts about human nature, far more than the coronavirus, will shape our future.
Perhaps you've noticed: Hospitals are asking you to come back for your routine care. Amongst the surge in caring for COVID-19 patients, elective care, especially remunerative procedural care, was pushed to the sidelines. One source suggests that overall cancer care has decreased by 37% during the pandemic.
Infectious disease models can also describe riots. The spread of coronavirus and violent protests share many features in common, shedding at least some light on the coming summer of discontent.
Royce Chen, M.D., an ophthalmologic surgeon at NY-Presbyterian Hospital, was looking at far more than eyes once the COVID-19 pandemic hit New York. He and other physicians were redeployed to the ICU to help care for the new influx of patients. His article addresses an interesting question - which specialties were hardest hit? And how did physicians in the New York area feel about the PPE provided for them? (Hint: not so good.)
Currently, COVID-19 vaccines are all the rage. Expectations are not only high, they are too high. ACSH friend, and former trustee, Dr. Paul Offit gives us a much-needed reality check. A vaccine, especially a very effective one, is unlikely to be in the cards anytime soon. Although it is always better to prevent an infection than treat one, antiviral drugs are likely to be the tools to control coronavirus well before a vaccine appears.Here's how Dr. Offit sees this playing out.
The COVID-19 lockdown is responsible for both the loss of economic activity and human lives. Two independent groups of researchers concluded that the lockdown may be costing more lives than it saves.